Report date: Nov 6,2024
Conflict count: 361874
Publisher: Oxford University Press
Title count: 223
Conflict count: 9361


==========================================================

Created: 2017-10-13 18:21:33
ConfID: 5030478
CauseID: 1415947315
JT: Neuro-Oncology
MD: Shu,2,1,16,2000,Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation
DOI: 10.1093/neuonc/2.1.16(Journal) (5030478-N)
==========================================================

Created: 2017-10-13 16:45:45
ConfID: 5030524
CauseID: 1415944671
JT: Neuro-Oncology
MD: Ueda,5,1,14,2003,Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis
DOI: 10.1093/neuonc/5.1.14(Journal) (5030524-N)
==========================================================

Created: 2017-10-13 13:17:01
ConfID: 5030525
CauseID: 1415936306
JT: Neuro-Oncology
MD: Frederick,2,3,159,2000,Analysis of genomic rearrangements associated with EGFRvIII expression suggests involvement of Alu repeat elements
DOI: 10.1093/neuonc/2.3.159(Journal) (5030525-N)
==========================================================

Created: 2017-10-13 15:27:13
ConfID: 5030523
CauseID: 1415941810
JT: Neuro-Oncology
MD: Jackson,3,3,193,2001,Limitations of stereotactic biopsy in the initial management of gliomas
DOI: 10.1093/neuonc/3.3.193(Journal) (5030523-N)
==========================================================

Created: 2017-10-13 17:40:15
ConfID: 5030550
CauseID: 1415946233
JT: Neuro-Oncology
MD: Kuriyama,4,3,179,2002,Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas
DOI: 10.1093/neuonc/4.3.179(Journal) (5030550-N)
==========================================================

Created: 2017-10-13 05:09:51
ConfID: 5063339
CauseID: 1415916568
JT: Neuro-Oncology
MD: Geoerger,2,2,103,2000,Antitumor activity of a human cytotoxic T-cell line (TALL-104) in brain tumor xenografts
DOI: 10.1093/neuonc/2.2.103(Journal) (5063339-N)
==========================================================

Created: 2017-10-13 11:19:50
ConfID: 5063703
CauseID: 1415932933
JT: Neuro-Oncology
MD: Chamberlain,1,2,120,1999,Epidural spinal cord compression: A single institution's retrospective experience
DOI: 10.1093/neuonc/1.2.120(Journal) (5063703-N)
==========================================================

Created: 2017-10-13 17:38:41
ConfID: 5064639
CauseID: 1415946051
JT: Neuro-Oncology
MD: Schold,2,1,34,2000,A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: A North American Brain Tumor Consortium study
DOI: 10.1093/neuonc/2.1.34(Journal) (5064639-N)
==========================================================

Created: 2017-10-13 04:20:41
ConfID: 5048397
CauseID: 1415914121
JT: Neuro-Oncology
MD: Davis,1,3,205,1999,Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base
DOI: 10.1093/neuonc/1.3.205(Journal) (5048397-N)
==========================================================

Created: 2017-10-13 06:04:15
ConfID: 5048398
CauseID: 1415920009
JT: Neuro-Oncology
MD: van den Bent,5,2,128,2003,Recent developments in the molecular characterization and treatment of oligodendroglial tumors
DOI: 10.1093/neuonc/5.2.128(Journal) (5048398-N)
==========================================================

Created: 2017-10-13 15:28:58
ConfID: 5048401
CauseID: 1415941846
JT: Neuro-Oncology
MD: Turner,4,2,102,2002,Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: The Duke experience
DOI: 10.1093/neuonc/4.2.102(Journal) (5048401-N)
==========================================================

Created: 2017-10-13 04:32:59
ConfID: 5015880
CauseID: 1415914759
JT: Neuro-Oncology
MD: Osoba,2,4,221,2000,Effect of disease burden on health-related quality of life in patients with malignant gliomas
DOI: 10.1093/neuonc/2.4.221(Journal) (5015880-N)
==========================================================

Created: 2017-10-13 13:16:55
ConfID: 5015881
CauseID: 1415936304
JT: Neuro-Oncology
MD: Raithatha,2,3,145,2000,Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas
DOI: 10.1093/neuonc/2.3.145(Journal) (5015881-N)
==========================================================

Created: 2017-10-13 17:00:15
ConfID: 5015882
CauseID: 1415944982
JT: Neuro-Oncology
MD: Glass,2,3,151,2000,Inhibition of cell growth in human glioblastoma cell lines by farnesyltransferase inhibitor SCH66336
DOI: 10.1093/neuonc/2.3.151(Journal) (5015882-N)
==========================================================

Created: 2017-10-13 12:59:20
ConfID: 5015876
CauseID: 1415935760
JT: Neuro-Oncology
MD: Hirano,1,2,109,1999,Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas
DOI: 10.1093/neuonc/1.2.109(Journal) (5015876-N)
==========================================================

Created: 2017-10-13 13:23:50
ConfID: 5015877
CauseID: 1415936447
JT: Neuro-Oncology
MD: ,1,1,27,1999,Pediatric Brain Tumor Foundation of the United States: Supporting the search for the cause and cure of childhood brain tumors
DOI: 10.1093/neuonc/1.1.27(Journal) (5015877-N)
==========================================================

Created: 2017-10-13 08:15:10
ConfID: 5015879
CauseID: 1415926122
JT: Neuro-Oncology
MD: Korones,5,2,116,2003,Do children with optic pathway tumors have an increased frequency of other central nervous system tumors?
DOI: 10.1093/neuonc/5.2.116(Journal) (5015879-N)
==========================================================

Created: 2017-10-13 11:01:26
ConfID: 5015902
CauseID: 1415932374
JT: Neuro-Oncology
MD: Comas,1,4,261,1999,Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors
DOI: 10.1093/neuonc/1.4.261(Journal) (5015902-N)
==========================================================

Created: 2017-10-13 14:42:54
ConfID: 5015898
CauseID: 1415940166
JT: Neuro-Oncology
MD: Wrensch,4,4,278,2002,Epidemiology of primary brain tumors: Current concepts and review of the literature
DOI: 10.1093/neuonc/4.4.278(Journal) (5015898-N)
==========================================================

Created: 2017-10-13 19:52:11
ConfID: 5015899
CauseID: 1415950048
JT: Neuro-Oncology
MD: Sembritzki,4,3,171,2002,Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein
DOI: 10.1093/neuonc/4.3.171(Journal) (5015899-N)
==========================================================

Created: 2017-10-13 04:25:11
ConfID: 5015945
CauseID: 1415914278
JT: Neuro-Oncology
MD: Hassall,3,4,251,2001,Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: Three case studies and a review of the literature
DOI: 10.1093/neuonc/3.4.251(Journal) (5015945-N)
==========================================================

Created: 2017-10-13 16:06:15
ConfID: 5015946
CauseID: 1415943377
JT: Neuro-Oncology
MD: Sanghavi,5,1,8,2003,A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: First report of the Children's Cancer Group-0952
DOI: 10.1093/neuonc/5.1.8(Journal) (5015946-N)
==========================================================

Created: 2017-10-13 04:20:46
ConfID: 4985338
CauseID: 1415914124
JT: Neuro-Oncology
MD: Collins,1,3,221,1999,CNS tumors and exposure to acrylonitrile: Inconsistency between experimental and epidemiology studies
DOI: 10.1093/neuonc/1.3.221(Journal) (4985338-N)
==========================================================

Created: 2017-10-13 16:16:22
ConfID: 4985230
CauseID: 1415943792
JT: Neuro-Oncology
MD: Robins,4,2,109,2002,A phase II trial of thymidine and carboplatin for recurrent malignant glioma: A North American Brain Tumor Consortium Study
DOI: 10.1093/neuonc/4.2.109(Journal) (4985230-N)
==========================================================

Created: 2017-10-13 14:52:55
ConfID: 4985231
CauseID: 1415940367
JT: Neuro-Oncology
MD: Kamitani,4,2,95,2002,Histone acetylation may suppress human glioma cell proliferation when p21WAF/Cip1 and gelsolin are induced
DOI: 10.1093/neuonc/4.2.95(Journal) (4985231-N)
==========================================================

Created: 2017-10-13 05:07:09
ConfID: 4985375
CauseID: 1415916480
JT: Neuro-Oncology
MD: Bodell,3,4,241,2001,Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors
DOI: 10.1093/neuonc/3.4.241(Journal) (4985375-N)
==========================================================

Created: 2017-10-13 04:02:27
ConfID: 4985376
CauseID: 1415913251
JT: Neuro-Oncology
MD: Biagi,2,4,239,2000,Primary Hodgkin's disease of the CNS in an immunocompetent patient: A case study and review of the literature
DOI: 10.1093/neuonc/2.4.239(Journal) (4985376-N)
==========================================================

Created: 2017-10-13 14:42:11
ConfID: 4985377
CauseID: 1415940152
JT: Neuro-Oncology
MD: Gilbert,4,4,261,2002,A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy
DOI: 10.1093/neuonc/4.4.261(Journal) (4985377-N)
==========================================================

Created: 2017-10-13 11:20:44
ConfID: 5051431
CauseID: 1415932983
JT: Neuro-Oncology
MD: Kunkel,3,2,82,2001,Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas
DOI: 10.1093/neuonc/3.2.82(Journal) (5051431-N)
==========================================================

Created: 2017-10-13 06:17:54
ConfID: 5051448
CauseID: 1415920766
JT: Neuro-Oncology
MD: Westphal,5,2,79,2003,A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma
DOI: 10.1093/neuonc/5.2.79(Journal) (5051448-N)
==========================================================

Created: 2017-10-13 06:06:54
ConfID: 5051447
CauseID: 1415920097
JT: Neuro-Oncology
MD: Ding,3,1,1,2001,Expression and hypoxic regulation of angiopoietins in human astrocytomas
DOI: 10.1093/neuonc/3.1.1(Journal) (5051447-N)
==========================================================

Created: 2017-10-13 15:03:20
ConfID: 5051446
CauseID: 1415940904
JT: Neuro-Oncology
MD: Visted,3,3,201,2001,Cell encapsulation technology as a therapeutic strategy for CNS malignancies
DOI: 10.1093/neuonc/3.3.201(Journal) (5051446-N)
==========================================================

Created: 2012-03-13 11:13:39
ConfID: 5002823
CauseID: 1349651443
JT: Neuro-Oncology
MD: Bigner,1,1,1,1999,Editorial
DOI: 10.1093/neuonc/1.1.1(Journal) (5002823-N)
==========================================================

Created: 2017-10-13 13:47:35
ConfID: 5036252
CauseID: 1415937135
JT: Neuro-Oncology
MD: Kunschner,3,3,167,2001,Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998
DOI: 10.1093/neuonc/3.3.167(Journal) (5036252-N)
==========================================================

Created: 2017-10-13 10:34:42
ConfID: 5036253
CauseID: 1415931195
JT: Neuro-Oncology
MD: Catania,3,2,89,2001,Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells
DOI: 10.1093/neuonc/3.2.89(Journal) (5036253-N)
==========================================================

Created: 2017-10-13 21:29:05
ConfID: 5036254
CauseID: 1415954300
JT: Neuro-Oncology
MD: Levin,2,1,22,2000,Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children
DOI: 10.1093/neuonc/2.1.22(Journal) (5036254-N)
==========================================================

Created: 2017-10-13 14:00:35
ConfID: 5036251
CauseID: 1415937493
JT: Neuro-Oncology
MD: Chiou,3,3,159,2001,Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy
DOI: 10.1093/neuonc/3.3.159(Journal) (5036251-N)
==========================================================

Created: 2017-10-13 04:20:34
ConfID: 5036223
CauseID: 1415914118
JT: Neuro-Oncology
MD: O'Neill,1,3,196,1999,The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: Cognitive function and performance status
DOI: 10.1093/neuonc/1.3.196(Journal) (5036223-N)
==========================================================

Created: 2017-10-13 16:49:34
ConfID: 5036214
CauseID: 1415944756
JT: Neuro-Oncology
MD: Fouladi,3,3,184,2001,Pleomorphic xanthoastrocytoma: Favorable outcome after complete surgical resection
DOI: 10.1093/neuonc/3.3.184(Journal) (5036214-N)
==========================================================

Created: 2017-10-13 17:44:19
ConfID: 5053983
CauseID: 1415946321
JT: Neuro-Oncology
MD: Levin,1,1,69,1999,Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: The past decade and where we are heading
DOI: 10.1093/neuonc/1.1.69(Journal) (5053983-N)
==========================================================

Created: 2017-10-13 13:31:48
ConfID: 5053993
CauseID: 1415936703
JT: Neuro-Oncology
MD: Kleihues,1,1,44,1999,Primary and secondary glioblastomas: From concept to clinical diagnosis
DOI: 10.1093/neuonc/1.1.44(Journal) (5053993-N)
==========================================================

Created: 2017-10-13 13:47:19
ConfID: 5053994
CauseID: 1415937131
JT: Neuro-Oncology
MD: Wiltshire,2,3,164,2000,Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classification
DOI: 10.1093/neuonc/2.3.164(Journal) (5053994-N)
==========================================================

Created: 2017-10-13 08:27:09
ConfID: 5006321
CauseID: 1415926663
JT: Neuro-Oncology
MD: Prados,5,2,96,2003,A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma
DOI: 10.1093/neuonc/5.2.96(Journal) (5006321-N)
==========================================================

Created: 2017-10-13 18:28:18
ConfID: 5006402
CauseID: 1415947463
JT: Neuro-Oncology
MD: Hochberg,2,1,29,2000,Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma
DOI: 10.1093/neuonc/2.1.29(Journal) (5006402-N)
==========================================================

Created: 2017-10-13 04:20:29
ConfID: 5006403
CauseID: 1415914115
JT: Neuro-Oncology
MD: Merchant,1,3,177,1999,Preliminary results of conformal radiation therapy for medulloblastoma
DOI: 10.1093/neuonc/1.3.177(Journal) (5006403-N)
==========================================================

Created: 2017-10-13 05:03:59
ConfID: 5006341
CauseID: 1415916363
JT: Neuro-Oncology
MD: Wooten,1,3,169,1999,A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution
DOI: 10.1093/neuonc/1.3.169(Journal) (5006341-N)
==========================================================

Created: 2017-10-13 15:31:41
ConfID: 5006336
CauseID: 1415942278
JT: Neuro-Oncology
MD: Lang,4,4,268,2002,Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies
DOI: 10.1093/neuonc/4.4.268(Journal) (5006336-N)
==========================================================

Created: 2017-10-13 11:19:56
ConfID: 5006388
CauseID: 1415932936
JT: Neuro-Oncology
MD: Duffner,1,2,152,1999,The treatment of malignant brain tumors in infants and very young children: An update of the Pediatric Oncology Group experience
DOI: 10.1093/neuonc/1.2.152(Journal) (5006388-N)
==========================================================

Created: 2017-10-13 14:47:34
ConfID: 5006390
CauseID: 1415940274
JT: Neuro-Oncology
MD: Kramer,3,3,211,2001,Electronic research: An opportunity for the Society for Neuro-Oncology
DOI: 10.1093/neuonc/3.3.211(Journal) (5006390-N)
==========================================================

Created: 2017-10-13 04:56:47
ConfID: 5006391
CauseID: 1415916014
JT: Neuro-Oncology
MD: Bartleson,5,2,121,2003,Reversible, strokelike migraine attacks in patients with previous radiation therapy
DOI: 10.1093/neuonc/5.2.121(Journal) (5006391-N)
==========================================================

Created: 2017-10-13 04:41:52
ConfID: 5056142
CauseID: 1415915125
JT: Neuro-Oncology
MD: Glick,3,4,258,2001,IMMUNOTHERAPY TASK FORCE FOR MALIGNANT BRAIN TUMORS April 21, 2001, Toronto, Ontario
DOI: 10.1093/neuonc/3.4.258(Journal) (5056142-N)
==========================================================

Created: 2017-10-13 13:48:26
ConfID: 5056155
CauseID: 1415937156
JT: Neuro-Oncology
MD: Schwarz,4,3,187,2002,Intravascular lymphomatosis presenting with a conus medullaris syndrome mimicking disseminated encephalomyelitis
DOI: 10.1093/neuonc/4.3.187(Journal) (5056155-N)
==========================================================

Created: 2017-10-13 18:16:51
ConfID: 5023852
CauseID: 1415947197
JT: Neuro-Oncology
MD: Sands,3,3,174,2001,Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: From the First International CNS Germ-Cell Tumor Study
DOI: 10.1093/neuonc/3.3.174(Journal) (5023852-N)
==========================================================

Created: 2017-10-13 12:44:52
ConfID: 5023851
CauseID: 1415935385
JT: Neuro-Oncology
MD: Bigner,1,1,52,1999,Morphologic and molecular genetic aspects of oligodendroglial neoplasms
DOI: 10.1093/neuonc/1.1.52(Journal) (5023851-N)
==========================================================

Created: 2017-10-13 16:55:35
ConfID: 5023868
CauseID: 1415944881
JT: Neuro-Oncology
MD: Woods,4,4,242,2002,Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells
DOI: 10.1093/neuonc/4.4.242(Journal) (5023868-N)
==========================================================

Created: 2017-10-13 18:10:05
ConfID: 5023869
CauseID: 1415946927
JT: Neuro-Oncology
MD: Eley,4,2,86,2002,A chromosomal region 7p11.2 transcript map: Its development and application to the study of EGFR amplicons in glioblastoma
DOI: 10.1093/neuonc/4.2.86(Journal) (5023869-N)
==========================================================

Created: 2010-08-31 16:10:44
ConfID: 4975358
CauseID: 1207793912
JT: Neuro-Oncology
MD: Bigner,4,4,241,2002,Editorial
DOI: 10.1093/neuonc/4.4.241(Journal) (4975358-N)
==========================================================

Created: 2017-10-13 05:59:02
ConfID: 4975344
CauseID: 1415919399
JT: Neuro-Oncology
MD: Cheng,2,2,87,2000,Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy
DOI: 10.1093/neuonc/2.2.87(Journal) (4975344-N)
==========================================================

Created: 2017-10-13 16:23:57
ConfID: 4975446
CauseID: 1415944010
JT: Neuro-Oncology
MD: Newsham,2,1,1,2000,Use of horizontal ultrathin gel electrophoresis to analyze allelic deletions in chromosome band 11p15.5 in gliomas
DOI: 10.1093/neuonc/2.1.1(Journal) (4975446-N)
==========================================================

Created: 2017-10-13 15:08:25
ConfID: 5040915
CauseID: 1415941010
JT: Neuro-Oncology
MD: Aldosari,4,2,75,2002,Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft
DOI: 10.1093/neuonc/4.2.75(Journal) (5040915-N)
==========================================================

Created: 2017-10-13 04:50:01
ConfID: 5040928
CauseID: 1415915766
JT: Neuro-Oncology
MD: Puzzilli,1,3,188,1999,Anterior clinoidal meningiomas: Report of a series of 33 patients operated on through the pterional approach
DOI: 10.1093/neuonc/1.3.188(Journal) (5040928-N)
==========================================================

Created: 2017-10-13 04:49:53
ConfID: 5040929
CauseID: 1415915763
JT: Neuro-Oncology
MD: Gurney,1,3,212,1999,Extremely low frequency electromagnetic fields (EMF) and brain cancer in adults and children: Review and comment
DOI: 10.1093/neuonc/1.3.212(Journal) (5040929-N)
==========================================================

Created: 2017-10-13 05:43:41
ConfID: 5040950
CauseID: 1415918761
JT: Neuro-Oncology
MD: Cairncross,2,2,114,2000,Myeloablative chemotherapy for recurrent aggressive oligodendroglioma
DOI: 10.1093/neuonc/2.2.114(Journal) (5040950-N)
==========================================================

Created: 2017-10-13 16:24:03
ConfID: 4975412
CauseID: 1415944011
JT: Neuro-Oncology
MD: Cohen,4,2,129,2002,Intractable vomiting from glioblastoma metastatic to the fourth ventricle: Three case studies
DOI: 10.1093/neuonc/4.2.129(Journal) (4975412-N)
==========================================================

Created: 2017-10-13 17:08:20
ConfID: 5057881
CauseID: 1415945171
JT: Neuro-Oncology
MD: Jukich,3,3,141,2001,Trends in incidence of primary brain tumors in the United States, 1985-1994
DOI: 10.1093/neuonc/3.3.141(Journal) (5057881-N)
==========================================================

Created: 2017-10-13 12:14:54
ConfID: 5057889
CauseID: 1415934552
JT: Neuro-Oncology
MD: Yokoyama,3,1,22,2001,Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro
DOI: 10.1093/neuonc/3.1.22(Journal) (5057889-N)
==========================================================

Created: 2017-10-13 15:43:52
ConfID: 4993400
CauseID: 1415942731
JT: Neuro-Oncology
MD: Giordana,4,2,115,2002,MDM2 overexpression is associated with short survival in adults with medulloblastoma
DOI: 10.1093/neuonc/4.2.115(Journal) (4993400-N)
==========================================================

Created: 2017-10-13 13:18:51
ConfID: 4993496
CauseID: 1415936343
JT: Neuro-Oncology
MD: Giese,1,1,3,1999,Thromboxane synthase regulates the migratory phenotype of human glioma cells
DOI: 10.1093/neuonc/1.1.3(Journal) (4993496-N)
==========================================================

Created: 2017-10-13 15:44:32
ConfID: 4993467
CauseID: 1415942752
JT: Neuro-Oncology
MD: Groothuis,2,1,45,2000,The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
DOI: 10.1093/neuonc/2.1.45(Journal) (4993467-N)
==========================================================

Created: 2017-10-13 05:35:29
ConfID: 5059320
CauseID: 1415918449
JT: Neuro-Oncology
MD: Meyers,5,2,89,2003,Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression
DOI: 10.1093/neuonc/5.2.89(Journal) (5059320-N)
==========================================================

Created: 2017-10-13 04:28:37
ConfID: 5059343
CauseID: 1415914426
JT: Neuro-Oncology
MD: Gollmer,2,2,80,2000,Expression of vascular endothelial growth factor-b in human astrocytoma
DOI: 10.1093/neuonc/2.2.80(Journal) (5059343-N)
==========================================================

Created: 2012-03-13 11:13:39
ConfID: 5059342
CauseID: 1349651443
JT: Neuro-Oncology
MD: Bigner,1,1,26,1999,PREFACE
DOI: 10.1093/neuonc/1.1.26(Journal) (5059342-N)
==========================================================

Created: 2017-10-13 07:10:12
ConfID: 5059330
CauseID: 1415923359
JT: Neuro-Oncology
MD: Mahoney,2,4,213,2000,Carboplatin is effective therapy for young children with progressive optic pathway tumors: A Pediatric Oncology Group phase II study
DOI: 10.1093/neuonc/2.4.213(Journal) (5059330-N)
==========================================================

Created: 2017-10-13 14:42:05
ConfID: 5060521
CauseID: 1415940151
JT: Neuro-Oncology
MD: Hukin,4,4,253,2002,Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors
DOI: 10.1093/neuonc/4.4.253(Journal) (5060521-N)
==========================================================

Created: 2017-10-13 04:28:31
ConfID: 5060520
CauseID: 1415914419
JT: Neuro-Oncology
MD: Fults,2,2,71,2000,Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas
DOI: 10.1093/neuonc/2.2.71(Journal) (5060520-N)
==========================================================

Created: 2017-10-13 12:54:40
ConfID: 5060522
CauseID: 1415935644
JT: Neuro-Oncology
MD: Kim,4,3,165,2002,Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences
DOI: 10.1093/neuonc/4.3.165(Journal) (5060522-N)
==========================================================

Created: 2017-11-29 09:28:14
ConfID: 5306688
CauseID: 1417633954
OtherID: 1417633430
JT: Neuro-Oncology
MD: ,19,12,1701,2017,Corrigenda
DOI: 10.1093/neuonc/nox102(Journal) (5306688-N)
DOI: 10.1093/neuonc/nox088(Journal)
DOI: 10.1093/neuonc/nox110(Journal)
==========================================================

Created: 2017-10-13 15:20:31
ConfID: 5044967
CauseID: 1415941665
JT: Neuro-Oncology
MD: Pipas,2,3,190,2000,Treatment of progressive metastatic glomus jugulare tumor (paraganglioma) with gemcitabine
DOI: 10.1093/neuonc/2.3.190(Journal) (5044967-N)
==========================================================

Created: 2017-10-13 12:51:48
ConfID: 5044925
CauseID: 1415935580
JT: Neuro-Oncology
MD: De Winter,1,4,275,1999,Brain tumors in children with neurofibromatosis: Additional neuropsychological morbidity?
DOI: 10.1093/neuonc/1.4.275(Journal) (5044925-N)